Imbalance in pro-inflammatory and anti-inflammatory cytokines milieu in B cells of children with autism.

Researchers studied immune cells called B cells in children with autism compared to typical children. They found that B cells in autistic children produce more inflammation-causing proteins and fewer inflammation-reducing proteins. This suggests the immune system in autism may be out of balance, with too much inflammation. When exposed to bacterial toxins, this imbalance became even worse in the autism group. This research helps explain why immune problems are common in autism.

This study examined immune dysfunction in autism by analyzing inflammatory and anti-inflammatory proteins (cytokines) produced by B cells - a type of immune cell. Researchers compared B cells from children with autism spectrum disorder (ASD) to typically developing children. They found that B cells from children with ASD produced higher levels of inflammatory cytokines (IL-6, TNF-α) and lower levels of anti-inflammatory cytokines (IL-10), suggesting an imbalanced immune response. When B cells were exposed to a bacterial component (LPS), this inflammatory imbalance was further amplified in the ASD group.

Treatment with an NF-kB inhibitor partially reduced this inflammatory response. The findings suggest B cells may contribute to immune dysfunction in autism through dysregulated cytokine production.

Findings suggest immune dysfunction in autism involves B cell dysregulation with pro-inflammatory bias. This may inform understanding of comorbid conditions and potential therapeutic targets. However, clinical significance requires validation in larger studies with detailed participant characterization and longitudinal follow-up.

Sample size not reported in abstract. Study type unclear. Cross-sectional design cannot establish causality. Limited to cytokine analysis in B cells only. No information about participant characteristics, age ranges, or potential confounding factors provided in abstract.

B cells play multiple roles in preservation of healthy immune system including management of immune responses by expression of pro- and anti-inflammatory cytokines. Several earlier studies have documented that B cells express both pro-inflammatory cytokines such as IL-6, TNF-α as well as anti-inflammatory cytokines such as IL-10. However, it is yet to be examined whether these pro-/anti-inflammatory cytokines are expressed in B cells of children with autism spectrum disorder (ASD). Pathophysiology of ASD begins in early childhood and is characterized by repetitive/restricted behavioral patterns, and dysfunction in communal/communication skills.

ASD pathophysiology also has a strong component of immune dysfunction which has been highlighted in numerous earlier publications. In this study, we specifically explored pro-/anti-inflammatory cytokines (IL-6, IL-17A, IFN-γ, TNF-α, IL-10) in B cells of ASD subjects and compared them typically developing control (TDC) children. Present study shows that inflammatory cytokines such as IL-6 and TNF-α are elevated in B cells of ASD subjects, while anti-inflammatory cytokine, IL-10 is decreased in ASD group when compared to TDC group. Further, TLR4 activation by its ligand, lipopolysaccharide (LPS) further upregulates inflammatory potential of B cells from ASD group by increasing IL-6 expression, whereas LPS has no significant effect on IL-10 expression in ASD group.

Furthermore, LPS-induced inflammatory signaling of IL-6 in B cells of ASD subjects was partially mitigated by the pretreatment with NF-kB inhibitor. Present study propounds the idea that B cells could be crucial players in causing immune dysfunction in ASD subjects through an imbalance in expression of pro-/anti-inflammatory cytokines.